After years of setbacks, dementia researchers are getting excited about a new antibody drug called lecanemab. No one expects it to stop cognitive decline, but even slowing it would be a breakthrough
The singer Billie Eilish has spoken about living with the condition that affects 300,000 people in the UK. For many, trying to suppress their tics is exhausting. But others have learned to control their symptoms and use the energy as a driving force